BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27634218)

  • 1. DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM).
    Guilleret I; Losi L; Chelbi ST; Fonda S; Bougel S; Saponaro S; Gozzi G; Alberti L; Braunschweig R; Benhattar J
    Biochem Biophys Res Commun; 2016 Oct; 479(2):231-237. PubMed ID: 27634218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation.
    Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
    J Pathol; 2006 Jan; 208(1):100-7. PubMed ID: 16278815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus.
    Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
    Oncogene; 2006 May; 25(21):3084-92. PubMed ID: 16407829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma.
    Smith E; De Young NJ; Pavey SJ; Hayward NK; Nancarrow DJ; Whiteman DC; Smithers BM; Ruszkiewicz AR; Clouston AD; Gotley DC; Devitt PG; Jamieson GG; Drew PA
    Mol Cancer; 2008 Oct; 7():75. PubMed ID: 18831746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma.
    Krause L; Nones K; Loffler KA; Nancarrow D; Oey H; Tang YH; Wayte NJ; Patch AM; Patel K; Brosda S; Manning S; Lampe G; Clouston A; Thomas J; Stoye J; Hussey DJ; Watson DI; Lord RV; Phillips WA; Gotley D; Smithers BM; Whiteman DC; Hayward NK; Grimmond SM; Waddell N; Barbour AP
    Carcinogenesis; 2016 Apr; 37(4):356-65. PubMed ID: 26905591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process.
    Wen X; Jeong S; Kim Y; Bae JM; Cho NY; Kim JH; Kang GH
    Clin Epigenetics; 2017; 9():1. PubMed ID: 28149329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.
    Kawakami K; Brabender J; Lord RV; Groshen S; Greenwald BD; Krasna MJ; Yin J; Fleisher AS; Abraham JM; Beer DG; Sidransky D; Huss HT; Demeester TR; Eads C; Laird PW; Ilson DH; Kelsen DP; Harpole D; Moore MB; Danenberg KD; Danenberg PV; Meltzer SJ
    J Natl Cancer Inst; 2000 Nov; 92(22):1805-11. PubMed ID: 11078757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic patterns in the progression of esophageal adenocarcinoma.
    Eads CA; Lord RV; Wickramasinghe K; Long TI; Kurumboor SK; Bernstein L; Peters JH; DeMeester SR; DeMeester TR; Skinner KA; Laird PW
    Cancer Res; 2001 Apr; 61(8):3410-8. PubMed ID: 11309301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors.
    Jin Z; Cheng Y; Olaru A; Kan T; Yang J; Paun B; Ito T; Hamilton JP; David S; Agarwal R; Selaru FM; Sato F; Abraham JM; Beer DG; Mori Y; Shimada Y; Meltzer SJ
    Int J Cancer; 2008 Nov; 123(10):2331-6. PubMed ID: 18729198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma.
    Brock MV; Gou M; Akiyama Y; Muller A; Wu TT; Montgomery E; Deasel M; Germonpré P; Rubinson L; Heitmiller RF; Yang SC; Forastiere AA; Baylin SB; Herman JG
    Clin Cancer Res; 2003 Aug; 9(8):2912-9. PubMed ID: 12912936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of the Ras-related associated with diabetes gene in human primary esophageal cancer.
    Jin Z; Feng X; Jian Q; Cheng Y; Gao Y; Zhang X; Wang L; Zhang Y; Huang W; Fan X; Chen S; Yu H; Zhao Z; Dong M; Liu J; Mori Y; Meltzer SJ
    Anticancer Res; 2013 Nov; 33(11):5199-203. PubMed ID: 24222170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation analysis on microdissected paraffin-embedded tissues using bisulfite treatment and PCR-SSCP.
    Bian YS; Yan P; Osterheld MC; Fontolliet C; Benhattar J
    Biotechniques; 2001 Jan; 30(1):66-72. PubMed ID: 11196322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics: DNA Methylation Analysis in Esophageal Adenocarcinoma.
    Islam F; Tang JC; Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():247-256. PubMed ID: 29600375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of DNA methylation by melt curve analysis.
    Smith E; Jones ME; Drew PA
    BMC Cancer; 2009 Apr; 9():123. PubMed ID: 19393074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
    Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
    J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker.
    Zare M; Jazii FR; Alivand MR; Nasseri NK; Malekzadeh R; Yazdanbod M
    BMC Cancer; 2009 Jan; 9():24. PubMed ID: 19149902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.
    Eads CA; Lord RV; Kurumboor SK; Wickramasinghe K; Skinner ML; Long TI; Peters JH; DeMeester TR; Danenberg KD; Danenberg PV; Laird PW; Skinner KA
    Cancer Res; 2000 Sep; 60(18):5021-6. PubMed ID: 11016622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
    Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
    World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.